Summary
0.78 0.03(3.60%)05/17/2024
Danimer Scientific Inc (DNMR)
Danimer Scientific Inc (DNMR)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 3.96 | 11.33 | -20.48 | 26.53 | -49.70 | -74.92 | 0.00 | -82.23 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 0.84 | |
| Open | 0.81 | |
| High | 0.88 | |
| Low | 0.81 | |
| Volume | 1,278,631 | |
| Change | 0.03 | |
| Change % | 3.96 | |
| Avg Volume (20 Days) | 736,617 | |
| Volume/Avg Volume (20 Days) Ratio | 1.74 | |
| 52 Week Range | 0.60 - 3.56 | |
| Price vs 52 Week High | -76.54% | |
| Price vs 52 Week Low | 39.17% | |
| Range | 3.09 | |
| Gap Up/Down | -0.02 | |
Fundamentals | ||
| Market Capitalization (Mln) | 87 | |
| EBIDTA | 0 | |
| PE Ratio | 0.0000 | |
| PEG Ratio | 0.0000 | |
| WallStreet Target Price | 25.33 | |
| Book Value | 5.2740 | |
| Earnings Per Share | -0.6730 | |
| EPS Estimate Current Quarter | -0.0800 | |
| EPS Estimate Next Quarter | -0.0700 | |
| EPS Estimate Current Year | -0.1700 | |
| EPS Estimate Next Year | -0.5100 | |
| Diluted EPS (TTM) | -0.6730 | |
| Revenues | ||
| Profit Marging | -0.9594 | |
| Operating Marging (TTM) | -1.3724 | |
| Return on asset (TTM) | -0.1097 | |
| Return on equity (TTM) | -0.1781 | |
| Revenue TTM | 53,048,000 | |
| Revenue per share TTM | 0.6980 | |
| Quarterly Revenue Growth (YOY) | 0.0420 | |
| Quarterly Earnings Growth (YOY) | 0.0000 | |
| Gross Profit (TTM) | 12,859,000 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 0.0000 | |
| Forward PE | 0.0000 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 2.3081 | |
| Revenue Enterprise Value | 20.4012 | |
| EBITDA Enterprise Value | 0.0000 | |
| Shares | ||
| Shares Outstanding | 100,344,000 | |
| Shares Float | 88,658,216 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 13.67 | |
| Institutions (%) | 49.47 | |
05/07 22:09 EST - seekingalpha.com
Danimer Scientific, Inc. (DNMR) Q1 2024 Earnings Call Transcript
Danimer Scientific, Inc. (NYSE:DNMR ) Q1 2024 Results Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Blake Chamblee - Director of Financial Reporting Stephen Croskrey - Chairman and Chief Executive Officer Mike Hajost - Chief Financial Officer Conference Call Participants Jon Tanwanteng - CJS Securities Dan Rizzo - Jefferies LLC Operator Greetings. Welcome to the Danimer Scientific 2024 First Quarter Earnings Call.
Danimer Scientific, Inc. (DNMR) Q1 2024 Earnings Call Transcript
Danimer Scientific, Inc. (NYSE:DNMR ) Q1 2024 Results Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Blake Chamblee - Director of Financial Reporting Stephen Croskrey - Chairman and Chief Executive Officer Mike Hajost - Chief Financial Officer Conference Call Participants Jon Tanwanteng - CJS Securities Dan Rizzo - Jefferies LLC Operator Greetings. Welcome to the Danimer Scientific 2024 First Quarter Earnings Call.
05/06 16:30 EST - businesswire.com
Danimer Scientific Reveals New Branding and New Applications Based on PHA During NPE 2024
BAINBRIDGE, Ga.--(BUSINESS WIRE)---- $DNMR--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next-generation bioplastics company focused on the development and production of PHA biopolymers, is unveiling new commercial applications and branding during NPE 2024, North America's largest plastics tradeshow, taking place this week in Orlando, FL. A more perfect polymer™ takes center stage at NPE 2024. Danimer's signature PHA, Nodax®, represents a more perfect polymer revolution.
Danimer Scientific Reveals New Branding and New Applications Based on PHA During NPE 2024
BAINBRIDGE, Ga.--(BUSINESS WIRE)---- $DNMR--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next-generation bioplastics company focused on the development and production of PHA biopolymers, is unveiling new commercial applications and branding during NPE 2024, North America's largest plastics tradeshow, taking place this week in Orlando, FL. A more perfect polymer™ takes center stage at NPE 2024. Danimer's signature PHA, Nodax®, represents a more perfect polymer revolution.
05/02 16:45 EST - businesswire.com
Danimer Scientific Announces Proposed Pro-Rata Distribution of Warrants to Purchase Common Stock
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Company” or “Danimer Scientific”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced a proposed pro-rata dividend distribution of warrants (“Dividend Warrants”) to holders of the Company's Class A Common Stock, par value $0.0001 per share (“Common Stock”) as of May 13, 2024 (“Record Date”). Subject to the Company's stockholders approving a p.
Danimer Scientific Announces Proposed Pro-Rata Distribution of Warrants to Purchase Common Stock
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Company” or “Danimer Scientific”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced a proposed pro-rata dividend distribution of warrants (“Dividend Warrants”) to holders of the Company's Class A Common Stock, par value $0.0001 per share (“Common Stock”) as of May 13, 2024 (“Record Date”). Subject to the Company's stockholders approving a p.
05/01 11:06 EST - zacks.com
Will Danimer Scientific, Inc. (DNMR) Report Negative Q1 Earnings? What You Should Know
Danimer Scientific (DNMR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Danimer Scientific, Inc. (DNMR) Report Negative Q1 Earnings? What You Should Know
Danimer Scientific (DNMR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
05/01 08:30 EST - businesswire.com
Danimer Scientific Announces Release Date for First Quarter 2024 Results
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading, next-generation bioplastics company focused on the development and production of biodegradable materials, announced today that the Company will release its first quarter 2024 financial results after the market closes on Tuesday May 7, 2024. A webcast and conference call will be held that same day at 4:30 p.m. Eastern Time to review the Company's first quarter results, discuss recent.
Danimer Scientific Announces Release Date for First Quarter 2024 Results
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading, next-generation bioplastics company focused on the development and production of biodegradable materials, announced today that the Company will release its first quarter 2024 financial results after the market closes on Tuesday May 7, 2024. A webcast and conference call will be held that same day at 4:30 p.m. Eastern Time to review the Company's first quarter results, discuss recent.
04/22 08:30 EST - businesswire.com
Danimer Scientific Announces $20 Million Asset-Based Revolving Credit Facility
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (the “Company” or “Danimer Scientific”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today, that on April 19, 2024, it entered into an asset-based revolving credit and security agreement with Mountain Ridge Capital secured primarily by the Company's accounts receivable and inventory. The credit and security agreement provides for borrowings un.
Danimer Scientific Announces $20 Million Asset-Based Revolving Credit Facility
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (the “Company” or “Danimer Scientific”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today, that on April 19, 2024, it entered into an asset-based revolving credit and security agreement with Mountain Ridge Capital secured primarily by the Company's accounts receivable and inventory. The credit and security agreement provides for borrowings un.
04/15 10:36 EST - zacks.com
Down -41.74% in 4 Weeks, Here's Why Danimer Scientific (DNMR) Looks Ripe for a Turnaround
The heavy selling pressure might have exhausted for Danimer Scientific (DNMR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Down -41.74% in 4 Weeks, Here's Why Danimer Scientific (DNMR) Looks Ripe for a Turnaround
The heavy selling pressure might have exhausted for Danimer Scientific (DNMR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
03/28 19:29 EST - seekingalpha.com
Danimer Scientific, Inc. (DNMR) Q4 2023 Earnings Call Transcript
Danimer Scientific, Inc. (DNMR) Q4 2023 Earnings Call Transcript
Danimer Scientific, Inc. (DNMR) Q4 2023 Earnings Call Transcript
Danimer Scientific, Inc. (DNMR) Q4 2023 Earnings Call Transcript
03/28 18:16 EST - zacks.com
Danimer Scientific, Inc. (DNMR) Reports Q4 Loss, Tops Revenue Estimates
Danimer Scientific, Inc. (DNMR) came out with a quarterly loss of $0.39 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.28 per share a year ago.
Danimer Scientific, Inc. (DNMR) Reports Q4 Loss, Tops Revenue Estimates
Danimer Scientific, Inc. (DNMR) came out with a quarterly loss of $0.39 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.28 per share a year ago.
03/28 16:01 EST - businesswire.com
Danimer Scientific Announces Fourth Quarter and Full Year 2023 Results
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its fourth quarter and full year, ended December 31, 2023. Stephen E. Croskrey, Chairman and Chief Executive Officer of Danimer, commented, “While 2023 was a challenging year for the Company, we are greatly encouraged by the successes we had a.
Danimer Scientific Announces Fourth Quarter and Full Year 2023 Results
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its fourth quarter and full year, ended December 31, 2023. Stephen E. Croskrey, Chairman and Chief Executive Officer of Danimer, commented, “While 2023 was a challenging year for the Company, we are greatly encouraged by the successes we had a.
03/25 16:15 EST - businesswire.com
Danimer Scientific Announces Closing of $15 Million Registered Direct Offering
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (the “Company” or “Danimer Scientific”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced the closing of its previously announced registered direct offering for the purchase and sale of 15,000,000 shares of common stock (or common stock equivalent in lieu thereof) at a purchase price of $1.00 per share (or per common stock equivalent in lieu.
Danimer Scientific Announces Closing of $15 Million Registered Direct Offering
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (the “Company” or “Danimer Scientific”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced the closing of its previously announced registered direct offering for the purchase and sale of 15,000,000 shares of common stock (or common stock equivalent in lieu thereof) at a purchase price of $1.00 per share (or per common stock equivalent in lieu.
03/20 21:15 EST - businesswire.com
Danimer Scientific Announces $15 Million Registered Direct Offering
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (the “Company” or “Danimer Scientific”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced that it has entered into a definitive agreement for the purchase and sale of 15,000,000 shares of common stock (or common stock equivalent in lieu thereof) at a purchase price of $1.00 per share (or per common stock equivalent in lieu thereof) and accomp.
Danimer Scientific Announces $15 Million Registered Direct Offering
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (the “Company” or “Danimer Scientific”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced that it has entered into a definitive agreement for the purchase and sale of 15,000,000 shares of common stock (or common stock equivalent in lieu thereof) at a purchase price of $1.00 per share (or per common stock equivalent in lieu thereof) and accomp.
03/20 08:30 EST - businesswire.com
Danimer Scientific Announces Preliminary Fourth Quarter and Full Year 2023 Results
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced preliminary results for its fourth quarter and full year, ended December 31, 2023. Stephen E. Croskrey, Chairman and Chief Executive Officer of Danimer, commented, “We are pleased that we continued our trend of year-over-year PHA revenue growth in the fourth quarte.
Danimer Scientific Announces Preliminary Fourth Quarter and Full Year 2023 Results
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced preliminary results for its fourth quarter and full year, ended December 31, 2023. Stephen E. Croskrey, Chairman and Chief Executive Officer of Danimer, commented, “We are pleased that we continued our trend of year-over-year PHA revenue growth in the fourth quarte.
02/22 08:30 EST - businesswire.com
Danimer Scientific Announces Successful Expansion of Rinnovo® Demonstration Plant Capacity
BAINBRIDGE, Ga.--(BUSINESS WIRE)---- $DNMR--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced it has successfully completed the expansion of its Rochester, NY demonstration plant in order to better serve partners for the testing of Rinnovo® polymers. Rinnovo® is a type of polyhydroxyalkanoate (“PHA”) synthesized using a thermocatalytic process, which the Co.
Danimer Scientific Announces Successful Expansion of Rinnovo® Demonstration Plant Capacity
BAINBRIDGE, Ga.--(BUSINESS WIRE)---- $DNMR--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced it has successfully completed the expansion of its Rochester, NY demonstration plant in order to better serve partners for the testing of Rinnovo® polymers. Rinnovo® is a type of polyhydroxyalkanoate (“PHA”) synthesized using a thermocatalytic process, which the Co.
01/29 17:00 EST - businesswire.com
Danimer Scientific Receives Continued Listing Standard Notice from NYSE
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading, next-generation bioplastics company focused on the production of biodegradable materials, announced that it received a notice from the New York Stock Exchange (“NYSE”) on January 23, 2024, that the Company is not currently in compliance with the NYSE's continued listing standard requiring listed-company stock to maintain an average closing price of not less than $1.00 per share over.
Danimer Scientific Receives Continued Listing Standard Notice from NYSE
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading, next-generation bioplastics company focused on the production of biodegradable materials, announced that it received a notice from the New York Stock Exchange (“NYSE”) on January 23, 2024, that the Company is not currently in compliance with the NYSE's continued listing standard requiring listed-company stock to maintain an average closing price of not less than $1.00 per share over.
01/18 16:30 EST - businesswire.com
Danimer Scientific Announces New Directors
BAINBRIDGE, Ga.--(BUSINESS WIRE)---- $DNMR--Danimer Scientific has appointed Dr. David Moody and Mr. Richard Altice as members of Danimer's Board of Directors.
Danimer Scientific Announces New Directors
BAINBRIDGE, Ga.--(BUSINESS WIRE)---- $DNMR--Danimer Scientific has appointed Dr. David Moody and Mr. Richard Altice as members of Danimer's Board of Directors.
11/14 19:03 EST - seekingalpha.com
Danimer Scientific, Inc. (DNMR) Q3 2023 Earnings Call Transcript
Danimer Scientific, Inc. (NYSE:DNMR ) Q3 2023 Earnings Call Transcript November 14, 2023 4:30 PM ET Company Participants James Palczynski - IR Steve Croskrey - Chairman and CEO Mike Hajost - CFO Conference Call Participants Jon Tanwanteng - CGS Securities Thomas Boyes - TD Cowen Charles Neivert - Piper Sandler Kevin Estok - Jefferies Operator Greetings. Welcome to the Danimer Scientific 2023 Third Quarter Earnings Call.
Danimer Scientific, Inc. (DNMR) Q3 2023 Earnings Call Transcript
Danimer Scientific, Inc. (NYSE:DNMR ) Q3 2023 Earnings Call Transcript November 14, 2023 4:30 PM ET Company Participants James Palczynski - IR Steve Croskrey - Chairman and CEO Mike Hajost - CFO Conference Call Participants Jon Tanwanteng - CGS Securities Thomas Boyes - TD Cowen Charles Neivert - Piper Sandler Kevin Estok - Jefferies Operator Greetings. Welcome to the Danimer Scientific 2023 Third Quarter Earnings Call.
11/14 18:47 EST - zacks.com
Danimer Scientific, Inc. (DNMR) Reports Q3 Loss, Misses Revenue Estimates
Danimer Scientific, Inc. (DNMR) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.30 per share a year ago.
Danimer Scientific, Inc. (DNMR) Reports Q3 Loss, Misses Revenue Estimates
Danimer Scientific, Inc. (DNMR) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.30 per share a year ago.
11/14 16:01 EST - businesswire.com
Danimer Scientific Announces Third Quarter 2023 Results
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next-generation bioplastics company focused on the development and production of highly engineered biodegradable materials, today announced financial results for its third quarter, ended September 30, 2023. Stephen E. Croskrey, Chairman and Chief Executive Officer of Danimer, commented, “We are excited to announce that new business awards associated with a large Quick Service Restaura.
Danimer Scientific Announces Third Quarter 2023 Results
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next-generation bioplastics company focused on the development and production of highly engineered biodegradable materials, today announced financial results for its third quarter, ended September 30, 2023. Stephen E. Croskrey, Chairman and Chief Executive Officer of Danimer, commented, “We are excited to announce that new business awards associated with a large Quick Service Restaura.
11/09 09:47 EST - zacks.com
Why Earnings Season Could Be Great for Danimer Scientific (DNMR)
Danimer Scientific (DNMR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Why Earnings Season Could Be Great for Danimer Scientific (DNMR)
Danimer Scientific (DNMR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.